Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

13 results
Display

Does Dual Antiplatelet Therapy Increase the Risk of Peptic Ulcer Disease?

Kim JJ, Kim N

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
EDTA-dependent Pseudothrombocytopenia Confirmed by Supplementation of Kanamycin: A Case Report

Ahn HL, Jo YI, Choi YS, Lee JY, Lee HW, Kim SR, Sim J, Lee W, Jin CJ

  • KMID: 1758681
  • Korean J Intern Med.
  • 2002 Mar;17(1):65-68.
EDTA-dependent pseudothrombocytopenia (PTCP) is the phenomenon of a spurious low platelet count due to EDTA-induced aggregation of platelets. Since the failure to recognize EDTA-dependent PTCP may result in incorrect diagnosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Influence of Anti-Platelet Resistance on the Development of Cerebral Ischemic Lesion after Carotid Artery Stenting

Song TJ, Suh SH, Min PK, Kim DJ, Kim BM, Heo JH, Kim YD, Lee KY

PURPOSE: Cerebral ischemic lesions are frequently observed after carotid artery stenting (CAS), and anti-platelet agents are used to prevent stent thrombosis and peri-procedural complications. However, despite the premedication, cerebral ischemic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Impact of Dual Antiplatelet Therapy on Peptic Ulcer Disease

Ahn DG, Kim BJ, Kim JW, Kim JG

BACKGROUND/AIMS: Increased incidence of coronary artery disease has led to the increased use of dual antiplatelet therapy composed of aspirin and clopidogrel. We investigated the incidence of gastrointestinal complications in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antiplatelet Effect of Clopidogrel Can Be Reduced by Calcium-Channel Blockers

Seo KD, Kim YD, Yoon YW, Kim JY, Lee KY

PURPOSE: Clopidogrel is metabolized by the hepatic cytochrome P450 (CYP) system into its active thiol metabolite. CYP3A4 is involved in the metabolism of both clopidogrel and dihydropyridine calcium channel blockers...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Correlation Between the CYP2C19 Phenotype Status and the Results of Three Different Platelet Function Tests in Cardiovascular Disease Patients Receiving Antiplatelet Therapy: An Emphasis on Newly Introduced Platelet Function Analyzer-200 P2Y Test

Li S, Choi JL, Guo LZ, Goh RY, Kim BR, Woo KS, Kim MH, Han JY

BACKGROUND: An association has been reported between CYP2C19 polymorphism and the altered antiplatelet activity of clopidogrel. We investigated this association using the newly introduced platelet function analyzer (PFA)-200 (INNOVANCE PFA-200...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Very Late Stent Thrombosis after Drug-Eluting Stent Implantation in a Patient without Aspirin and Clopidogrel Resistance

Lim SY, Kim KS, Joo SJ, Jeong MH

Very late stent thrombosis (VLST) after implantation of drug-eluting stent is rare, but very fatal complication after percutaneous coronary intervention. We report a case of VLST of a sirolimus-eluting Cypher(TM)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Cilostazol on Platelet Activation in Coronary Stenting Patients Who Already Treated with Aspirin and Clopidogrel

Ahn JC, Song WH, Kwon JA, Park CG, Seo HS, Oh DJ, Rho YM

  • KMID: 1109521
  • Korean J Intern Med.
  • 2004 Dec;19(4):230-236.
BACKGROUND: A recent study has shown that triple anti-platelet therapy (cilostazol+clopidogrel+aspirin) resulted in a significantly lower restenosis rate after coronary stenting than did conventional therapy (clopidogrel+aspirin). However, the anti-platelet effects...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Beraprost Sodium on Subjective Symptoms in Diabetic Patients with Peripheral Arterial Disease

Yoon HS, Choi WJ, Sung IH, Lee HS, Chung HJ, Lee JW

BACKGROUND: This study evaluated the effects of Beraprost sodium (Berasil) on subjective leg symptoms in patients with peripheral arterial disease caused by diabetes mellitus. METHODS: Ninety-four diabetic patients with peripheral arterial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Triflusal on Primary Vascular Dysregulation Compared with Aspirin: A Double-Blind, Randomized, Crossover Trial

Shin S, Kim KJ, Cho IJ, Hong GR, Jang Y, Chung N, Rah YM, Chang HJ

PURPOSE: Primary vascular dysregulation (PVD) is a condition in which the response to cold temperature or external stimuli is abnormal. We investigated whether triflusal use results in amelioration of PVD...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-Term Clinical Benefits of a Platelet Glycoprotein IIb/IIIa Receptor Blocker, Abciximab (ReoPro (R) ), in High-Risk Diabetic Patients undergoing Percutaneous Coronary Intervention

Sim DS, Jeong MH, Kim W, Rhew JY, Yum JH, Kim JH, Cho JG, Ahn YK, Park JC, Ahn BH, Kim SH, Kang JC

  • KMID: 759651
  • Korean J Intern Med.
  • 2003 Sep;18(3):129-137.
BACKGROUND: High-risk percutaneous coronary interventions (PCIs) are associated with a high complication rate, a low procedural success rate and a high restenosis rate, especially in diabetics. We sought to determine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Successful Primary Coronary Intervention for the Total Occlusion of Left Main Stem with the Aid of Abciximab

Jeong MH, Ahn YK, Park JC, Ahn BH, Na KJ, Kim NH, Kim KH, Cho JG, Park JC, Kim SH, Kang JC

A 61-yr-old male patient presented with severe chest pain with cardiogenic shock due to an extensive anterolateral myocardial infarction. Two-dimensional echocardiogram showed severe left ventricular systolic dysfunction (ejection fraction=17%). Emergent...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Little Impact of Antiplatelet Agents on Venous Thromboembolism after Hip Fracture Surgery

Ji HM, Lee YK, Ha YC, Kim KC, Koo KH

Since the late 1980s, low dose aspirin has been used to prevent stroke and ischemic heart disease. However, prophylactic effect of antiplatelets against venous thromboembolism (VTE), in patients who undergo...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr